Inventor · disambiguated record
Thomas Muster
Also filed as: MUSTER THOMAS
25 granted patents·15 pending applications·336 citations·filing 1993–2021
96Inventor score
Files withAVIR GREEN HILLS BIOTECHNOLOGY7MUSTER THOMAS6SINAI SCHOOL MEDICINE4KATINGER HERMANN3PALESE PETER3
Top patents by PatentIndex Score
40 records- 0192US8057803B2Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsPALESE PETER·Filed 2008·Granted Nov 15, 2011·12 cites·43 claims
- 0292US6669943B1Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsSINAI SCHOOL MEDICINE·Filed 1999·Granted Dec 30, 2003·61 cites·21 claims
- 0391US6866853B2Interferon inducing genetically engineered attenuated virusesSINAI SCHOOL MEDICINE·Filed 2002·Granted Mar 15, 2005·31 cites·23 claims
- 0490US7588768B2Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsSINAI SCHOOL MEDICINE·Filed 2003·Granted Sep 15, 2009·21 cites·37 claims
- 0587US6468544B1Interferon inducing genetically engineered attenuated virusesSINAI SCHOOL MEDICINE·Filed 1999·Granted Oct 22, 2002·73 cites·9 claims
- 0685US5866694APeptides that induce antibodies which neutralize genetically divergent HIV-1 isolatesKATINGER HERMANN·Filed 1997·Granted Feb 2, 1999·52 cites·18 claims
- 0780US9187732B2Replication deficient influenza virus for the expression of heterologous sequencesBAXTER HEALTHCARE SA·Filed 2013·Granted Nov 17, 2015·3 cites·19 claims
- 0880US8765139B2Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsPALESE PETER·Filed 2011·Granted Jul 1, 2014·2 cites·28 claims
- 0977US9387240B2Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Jul 12, 2016·1 cites·20 claims
- 1074US8741301B2Method for generation of RNA virusMUSTER THOMAS·Filed 2009·Granted Jun 3, 2014·0 cites·1 claims
- 1173US5756674APeptides that induce antibodies which neutralize genetically divergent HIV-1 isolatesKATINGER HERMANN·Filed 1995·Granted May 26, 1998·31 cites·8 claims
- 1272US7510862B2Polynucleotide fragments of an infectious human endogenous retrovirusAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2002·Granted Mar 31, 2009·4 cites·2 claims
- 1370US10125374B2Influenza virus vector for virotherapyMUSTER THOMAS·Filed 2014·Granted Nov 13, 2018·1 cites·16 claims
- 1469US8778357B2Method for generation of RNA virusMUSTER THOMAS·Filed 2009·Granted Jul 15, 2014·0 cites·19 claims
- 1569US2010158942A1Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsPALESE PETER·Filed 2009·Application pending·0 cites
- 1667US2010233785A1Novel methods and interferon deficient substrates for the propagation of virusesBRANDT SABINE·Filed 2009·Application pending·0 cites
- 1765US8008460B2Polynucleotide fragments of an infectious human endogenous retrovirusAVIR GREEN HILLS BIOTECHNOLOGY RES DEV TRADE AG·Filed 2008·Granted Aug 30, 2011·0 cites·13 claims
- 1865US5693752APeptides that induce antibodies which neutralize genetically divergent HIV-1 isolatesKATINGER HERMANN·Filed 1994·Granted Dec 2, 1997·22 cites·13 claims
- 1964US2016279227A1Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticalsICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Application pending·0 cites
- 2060US8691238B2High growth reassortant influenza A virusMUSTER THOMAS·Filed 2009·Granted Apr 8, 2014·0 cites·17 claims
- 2159US10570376B2Method for influenza virus purificationBia Separations Doo·Filed 2015·Granted Feb 25, 2020·1 cites·10 claims
- 2258US2009123495A1Immune Response Inducing PreparationsAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2006·Application pending·0 cites
- 2357US2012237527A1Polynucleotide Fragments of an Infectious Human Endogenous RetrovirusWOLFF KLAUS·Filed 2012·Application pending·0 cites
- 2455US2008008717A1Polynucleotide Fragments of an Infectious Human Endogenous RetrovirusAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2007·Application pending·0 cites
- 2554US8541553B2Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoproteinHUMER JOHANNES·Filed 2008·Granted Sep 24, 2013·0 cites·2 claims
- 2654US6022726AGenetically engineered attenuated virusesFiled 1993·Granted Feb 8, 2000·21 cites·30 claims
- 2753US2010136052A1Replication deficient influenza virus for the expression of heterologous sequencesAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2008·Application pending·0 cites
- 2852US9771564B2Influenza virusMUSTER THOMAS·Filed 2010·Granted Sep 26, 2017·0 cites·10 claims
- 2951US10480013B2Influenza virus vector for virotherapyBLUE SKY VACCINES GMBH·Filed 2018·Granted Nov 19, 2019·0 cites·14 claims
- 3048US12447204B2Prime-boost influenza vaccineVIVALDI BIOSCIENCES INC·Filed 2020·Granted Oct 21, 2025·0 cites·14 claims
- 3148US2018016560A1Novel influenza virusNANOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3246US2011268764A1Immune response inducing preparationsAVIR GREEN HILLS BIOTECHNOLOGY RES DEV TRADE AG·Filed 2011·Application pending·0 cites
- 3344US2023414745A1Influenza virus encoding a truncated ns1 protein and a sars-cov receptor binding domainVIVALDI BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3443US2010129399A1Linear expression constructs for production of influenza virus particlesAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2008·Application pending·0 cites
- 3542US12350325B2Recombinant high growth rate influenza virus comprising mutations in M1, NS2, and PB2BLUESKY IMMUNOTHERAPIES GMBH·Filed 2020·Granted Jul 8, 2025·0 cites·14 claims
- 3640US2009130129A1Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic useAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2006·Application pending·0 cites
- 3740US2010285509A1Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic UseMAYER BERND·Filed 2010·Application pending·0 cites
- 3838US2013183740A1Novel method for generation of rna virusMUSTER THOMAS·Filed 2011·Application pending·0 cites
- 3936US2010158944A1Method for influenza virus protectionPETERKA MATJAZ·Filed 2007·Application pending·0 cites
- 4030US7282599B2Dithiocarbamate antiviral agents and methods of using sameAVIR GREEN HILLS BIOTECHNOLOGY·Filed 2002·Granted Oct 16, 2007·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Muster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →